Medical marijuana can be addictive. Roughly 1 in 4 people who use medicinal cannabis meet the criteria for a cannabis use disorder, according to a systematic review pooling data across multiple studies. That rate is lower than what you’d see with opioid painkillers, but it’s far from negligible, and it’s higher than many patients expect when they first get a prescription.
How Cannabis Creates Dependency
THC, the compound in marijuana responsible for the high, plugs directly into your brain’s reward circuitry. It raises baseline levels of dopamine, the chemical your brain uses to signal pleasure and motivation. Over time, your brain adjusts to this artificial boost. It produces less dopamine on its own and becomes less sensitive to the dopamine it does produce. The result is that everyday activities feel less rewarding, while cannabis feels increasingly necessary just to feel normal.
Cues tied to cannabis use, like the smell, the routine of preparing it, or being in a place where you usually use it, can trigger sharp spikes in dopamine that produce cravings. This is the same mechanism that drives craving in other substance use disorders. It’s not a matter of willpower. It’s a neurological pattern that reinforces itself with repeated use.
Addiction Rates in Medical Users
The best available estimate puts the prevalence of cannabis use disorder among medical marijuana patients at about 25%. When researchers narrowed the window to people who had used medicinal cannabis within the past 6 to 12 months, the rate climbed slightly to 29% under current diagnostic standards. Among chronic pain patients specifically, the most common group seeking medical cannabis, one study found problematic use in about 21% of patients.
For comparison, roughly 1 in 10 people who use cannabis in any context develop an addiction. The higher rate among medical users likely reflects frequency: medical patients tend to use cannabis daily or near-daily, which is the usage pattern most strongly linked to dependency.
Tolerance, Dependence, and Addiction Are Different
These three terms describe a progression, and many medical marijuana patients experience the first two without ever reaching the third.
- Tolerance means you need more of the substance to get the same effect. Your body has adapted to the dose. This is common and happens with many medications, not just cannabis.
- Physical dependence means your body has adjusted to having the substance present, and you experience withdrawal symptoms when you stop. Among chronic pain patients using medical cannabis in one Michigan study, nearly 68% reported at least one moderate or severe withdrawal symptom. That’s dependence, and it doesn’t necessarily mean addiction.
- Addiction adds compulsive use despite harm: you keep using even when it’s damaging your relationships, your work, or your health, and you struggle to cut back even when you want to.
One reassuring finding: among daily medical cannabis users in the same Michigan study, 97% reported no dose escalation over six months. For many patients, tolerance stabilizes rather than spiraling upward.
What Withdrawal Feels Like
If you’ve been using medical marijuana daily for at least a few months and you stop, withdrawal symptoms typically start within 24 to 48 hours. The early phase brings insomnia, irritability, reduced appetite, shakiness, and sometimes sweating or chills. These symptoms usually peak between days 2 and 6, then improve over the first week as THC clears your system.
A second wave can follow. Anger, aggression, and depressed mood often peak around two weeks after stopping. Sleep problems can linger for several weeks or longer. Among medical cannabis patients, the most commonly reported withdrawal symptoms are sleep difficulties (about 50%), followed by anxiety (28%), irritability (27%), and appetite changes (25%). The experience is genuinely uncomfortable but not medically dangerous in the way that alcohol or benzodiazepine withdrawal can be.
What Raises Your Risk
Genetics account for 50 to 70% of the variation in who develops problematic cannabis use. If addiction runs in your family, your risk is meaningfully higher. During adolescence and early adulthood, environment matters more, with factors like peer behavior, availability, and parental monitoring playing a larger role. Genetics become increasingly relevant in your late twenties and beyond.
Childhood adversity, including abuse and family instability, is another major contributor, affecting both the likelihood of starting cannabis and the likelihood of progressing to dependency. One study found a specific genetic variant that moderated the link between childhood adversity and cannabis dependence, suggesting these risk factors interact rather than operate independently.
Product potency matters too. A Lancet Psychiatry systematic review found that higher-potency cannabis products, those with greater THC concentrations, are associated with increased risk of cannabis use disorder compared to lower-potency products. As concentrates and high-THC strains become more common in dispensaries, this is worth paying attention to.
Starting before age 18 also significantly increases addiction risk.
How Cannabis Compares to Other Medications
Cannabis is less addictive than opioids, which carry a well-documented risk of severe dependency, overdose, and death. It’s also less addictive than benzodiazepines, which produce dangerous physical withdrawal. But “less addictive than opioids” is a low bar. Cannabis use disorder is a real clinical condition that affects a substantial minority of users, and the 25% rate among medical patients is higher than many people assume when choosing cannabis as an alternative to other pain treatments.
Treatment for Cannabis Use Disorder
No medication has proven clearly effective for treating cannabis addiction on its own. The gold standard is a combination of three behavioral therapies: cognitive behavioral therapy, which helps you identify triggers and build coping strategies; motivational enhancement therapy, which works through your ambivalence about changing; and contingency management, which uses tangible rewards for meeting goals like negative drug tests or attending sessions. Combined, these three approaches reliably reduce how much and how often people use, though sustained abstinence rates remain modest and tend to decline after treatment ends.
Antidepressants and anti-anxiety medications haven’t shown much value for treating the cannabis use disorder itself, though they may help with co-occurring depression or anxiety. One anticonvulsant medication showed promise in a small trial, reducing both cannabis use and withdrawal symptoms compared to placebo, but it hasn’t become a standard treatment.
Recognizing a Problem
A cannabis use disorder diagnosis requires meeting at least 2 of 11 criteria. Two or three criteria indicate mild severity, four or five moderate, and six or more severe. The criteria include things like using more than you intended, spending a lot of time obtaining or recovering from cannabis, giving up activities you used to enjoy, continuing to use despite it causing problems in your relationships, and experiencing cravings. Tolerance and withdrawal count as criteria but aren’t sufficient on their own for a diagnosis.
The line between responsible medical use and problematic use can blur gradually. If you notice you’re using more than your condition requires, using it in situations where it’s risky, or feeling unable to cut back when you try, those are signals worth taking seriously.